{"mainPropery":{"diseaseId":8616,"diseaseName":"Systemic mastocytosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8616/systemic-mastocytosis","synonyms":["Systemic mast cell disease","SMCD","Indolent systemic mastocytosis","Agressive systemic mastocytosis","Systemic mastocytosis with associated hemotologic non-mast cell lineage disease (SM-AHNMD)","Mast cell leukemia"],"synonyms-with-source":[{"name":"Systemic mast cell disease"},{"name":"SMCD"},{"name":"Indolent systemic mastocytosis"},{"name":"Agressive systemic mastocytosis"},{"name":"Systemic mastocytosis with associated hemotologic non-mast cell lineage disease (SM-AHNMD)"},{"name":"Mast cell leukemia"}],"identifiers":[{"identifierType":"OMIM","identifierId":"154800"},{"identifierType":"ORPHANET","identifierId":"2467"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases"}],"organizations":[{"resourceID":569,"resourceName":"The Mast Cell Disease Society","abbreviation":"","address1":"P.O. Box 416","address2":"","address3":"","address4":"","address5":"","city":"Sterling","state":"MA","zip":"01564","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"info@tmsforacure.org","url":"https://tmsforacure.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/154800' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%28Systemic%5BTitle%5D%20AND%20mastocytosis%5BTitle%5D%29%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Systemic mastocytosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Systemic+mastocytosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Systemic mastocytosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/mastocytosis-and-mast-cell-activation-disorders' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0024899/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/441/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/203948-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2467' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merck.com/mmhe/sec16/ch185/ch185e.html' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1559,"resourceId":2185,"resourceName":"National Institute of Allergy and Infectious Diseases","descriptionText":"The <a href='http://www.niaid.nih.gov/topics/mastocytosis/Pages/Default.aspx' target='_blank'>National Institute of Allergy and Infectious Diseases</a> (NIAID) supports scientists developing better ways to diagnose, treat, and prevent the many infectious, immunologic, and allergic diseases that afflict people worldwide.  Click on the link to view information on&nbsp;this topic.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/immunology-allergic-disorders/allergic-autoimmune-and-other-hypersensitivity-disorders/mastocytosis' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Systemic mastocytosis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1906,"resourceId":569,"resourceName":"The Mast Cell Disease Society","descriptionText":"The  Mast Cell Disease Society has a listing of <a href='http://tmsforacure.org/patients/research_centers_1.php' target='_blank'>Medical Research Centers</a> that specialize in mastocytosis. Click on the link to view this list which includes centers in the United States and Europe.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:612867' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2756,"resourceId":569,"resourceName":"The Mast Cell Disease Society","descriptionText":"The <a href='https://tmsforacure.org/physician-database/database/' target='_blank'>Mast Cell Disease Society</a> maintains a Physician Database where you can search for physicians that specialize in&nbsp;Systemic mastocytosis.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2757,"resourceId":569,"resourceName":"The Mast Cell Disease Society","descriptionText":"The <a href='https://tmsforacure.org/overview/' target='_blank'>Mast Cell Disease Society</a> provides information about mast cell diseases, including&nbsp;Systemic mastocytosis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":3498,"questionText":"What is systemic mastocytosis?","answerText":"<strong>Systemic mastocytosis (SM)</strong> is a form of <a href=\"http://rarediseases.info.nih.gov/gard/6987/mastocytosis/resources/1\" target=\"_blank\">mastocytosis</a> in which <a href=\"http://www.nhs.uk/Conditions/Mastocytosis/Pages/Introduction.aspx#mastcells\" target=\"_blank\">mast cells</a> accumulate in internal tissues and organs such as the liver, spleen, bone marrow, and small intestines. It is typically diagnosed in adults. Signs and symptoms vary based on which parts of the body are affected. The disorder is usually caused by&nbsp;<a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46586\" target=\"_blank\">somatic</a>&nbsp;changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/KIT\" target=\"_blank\"><em>KIT</em></a> gene.[8372][4923] Most cases are <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadic</a>&nbsp;and not inherited, but familial cases rarely have  been reported.[9100]&nbsp;<br />\r\n<br />\r\nSystemic mastocytosis can be divided into 4 main categories which are distinguished by various features:[12145]<br />\r\n<ul>\r\n    <li><a href=\"http://www.orpha.net/consor/www/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=98848\" target=\"_blank\">Indolent systemic mastocytosis</a> (ISM)</li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&amp;Expert=98849\" target=\"_blank\">Systemic mastocytosis with an associated hematologic nonmast cell lineage disorder</a> (SM-AHNMD)</li>\r\n    <li><a href=\"http://www.orpha.net/consor/www/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=98850\" target=\"_blank\">Aggressive systemic mastocytosis</a> (ASM)</li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&amp;Expert=98851\" target=\"_blank\">Mast cell leukemia</a> (MCL)</li>\r\n</ul>\r\nOnce a person is diagnosed, the category of SM must be determined, as treatment and prognosis differ for each.[12145]","dateModified":"2016-09-06T00:00:00"},"basicQuestions":[{"questionId":8964,"questionText":"What are the signs and symptoms of systemic mastocytosis?","answerText":"In systemic mastocytosis (SM), mast cells accumulate in internal organs such as the liver, spleen, bone marrow, and small intestines. The signs and symptoms vary based on which parts of the body are affected but may include:[8372][4923]\r\n<ul>\r\n    <li>Anemia and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001304.htm\" target=\"_blank\">bleeding disorders</a></li>\r\n    <li>Gastrointestinal symptoms such as abdominal pain, diarrhea, nausea, and/or vomiting</li>\r\n    <li>Itching, hives, and/or flushing of the skin</li>\r\n    <li><a href=\"http://www.nationaljewish.org/healthinfo/conditions/allergy/types/anaphylaxis/like-reactions.aspx\" target=\"_blank\">Anaphylactoid</a> reactions</li>\r\n    <li>Enlarged liver (hepatomegaly), spleen (splenomegaly), and lymph nodes (lymphadenopathy)</li>\r\n</ul>\r\nThere are four main types of systemic mastocytosis which vary in severity. They include:[12145]\r\n<ul>\r\n    <li>Indolent systemic mastocytosis - the most common form of SM with a slowly progressive (worsening over time) clinical course</li>\r\n    <li>Systemic mastocytosis with an associated hematologic nonmast cell lineage disorder - a form of SM  associated with other blood disorders (such as <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myeloproliferative-neoplasm?redirect=true\" target=\"_blank\">myeloproliferative</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/myelodysplasticsyndromes.html\" target=\"_blank\">myelodysplastic</a> conditions)</li>\r\n    <li>Aggressive systemic mastocytosis - a severe form of SM  usually characterized by organ impairment or organ failure due to aggressive mast cell infiltration</li>\r\n    <li>Mast cell leukemia - a very rare and aggressive form of SM that is associated with greater than 10% immature mast cells in the <a href=\"https://labtestsonline.org/understanding/analytes/blood-smear/tab/test\" target=\"_blank\">peripheral blood</a> or greater than 20% immature mast cells in <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003682.htm\" target=\"_blank\">bone marrow cultures</a> </li>\r\n</ul>","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":4923,"authors":"Koyamangalath Krishnan","articleTitle":"Systemic Mastocytosis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 22, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/203948-workup#showall","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8372,"authors":"Bundra K and Akin C","articleTitle":"Mastocytosis","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/mastocytosis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12145,"authors":"Mariana C Castells and Cem Akin","articleTitle":"Systemic mastocytosis: Determining the category of disease","bookWebsiteJournalTitle":"UpToDate","date":"August, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":8966,"questionText":"What causes systemic mastocytosis?","answerText":"Most cases of systemic mastocytosis are caused by <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46586\" target=\"_blank\">somatic mutations</a>  in the <a href=\"http://ghr.nlm.nih.gov/gene/KIT\" target=\"_blank\"><em>KIT</em></a> gene. This <a href=\"http://www.genome.gov/Glossary/index.cfm?id=70\" target=\"_blank\">gene</a> encodes a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> that helps control many important cellular processes such as cell growth and division; survival; and movement. This protein is also important for the development of certain types of cells, including mast cells (<a href=\"http://www.niaid.nih.gov/topics/immuneSystem/Pages/immuneCells.aspx\" target=\"_blank\">immune cells</a> that are important for the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000821.htm\" target=\"_blank\">inflammatory response</a>). Mutations in the <em>KIT</em> gene can leads to an overproduction of mast cells, which then accumulate in internal organs and lead to the symptoms of this condition.[8373][4923]","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":4923,"authors":"Koyamangalath Krishnan","articleTitle":"Systemic Mastocytosis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 22, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/203948-workup#showall","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8373,"authors":"","articleTitle":"KIT","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/gene/KIT","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8967,"questionText":"Is systemic mastocytosis inherited?","answerText":"Most cases of systemic mastocytosis (SM) are <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadic</a>&nbsp;(not inherited), occurring&nbsp;in people with no family history of the condition. The genetic mutations that often cause SM are&nbsp;<a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46586\" target=\"_blank\">somatic</a>, which means they are acquired after conception and are only present in certain cells. Because they are not present in the <a href=\"http://ghr.nlm.nih.gov/glossary=germcells\" target=\"_blank\">germ cells</a> (egg and sperm), they are not passed on to the next generation.[8372]<br />\r\n<br />\r\nRarely, SM has been reported in more than one family member. In this case, it may be inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.[9100]&nbsp;Mutations that cause autosomal dominant conditions are located in the germ cells. To be affected with an autosomal dominant condition, a person needs to have a mutation&nbsp;in only one copy of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell. A person with this form of SM has a 50% chance with each pregnancy of passing the mutation to his or her child.","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":8372,"authors":"Bundra K and Akin C","articleTitle":"Mastocytosis","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/mastocytosis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9100,"authors":"de Melo Campos P, Machado-Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte AS, Barra FF, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Olalla Saad ST, and Traina F","articleTitle":"Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412","bookWebsiteJournalTitle":"Leuk Res","date":"October 2014","volume":"38(10)","pages":"1245-1251","url":"https://www.ncbi.nlm.nih.gov/pubmed/25139846","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":5929,"questionText":"How is systemic mastocytosis diagnosed?","answerText":"A diagnosis of systemic mastocytosis (SM)&nbsp;is often suspected based on the presence of characteristic <a href=\"https://rarediseases.info.nih.gov/gard/8616/systemic-mastocytosis/resources/9\" target=\"_blank\">signs and symptoms</a>. Additional testing can then be ordered to rule out other conditions with similar features; confirm the diagnosis; determine the type; and assess the severity. These tests may include:[4923]\r\n<ul>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003934.htm\" target=\"_blank\">Bone marrow biopsy</a>&nbsp;- the most useful test used to diagnose the condition</li>\r\n    <li><a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/bdt/\" target=\"_blank\">Blood studies</a>&nbsp;- may show <a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=\"_blank\">anemia</a>, elevated <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19333.htm\" target=\"_blank\">histamine</a> levels, <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/thcp/\" target=\"_blank\">thrombocytopenia</a>, high white blood cell count (leukocytosis), low blood <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003480.htm\" target=\"_blank\">albumin</a> levels (hypoalbuminemia), or high serum <a href=\"http://labtestsonline.org/understanding/analytes/tryptase/tab/sample\" target=\"_blank\">tryptase</a> levels</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/diagnosticimaging.html\" target=\"_blank\">Imaging studies</a>&nbsp;- may help to identify the extent and stage of the disease</li>\r\n    <li>Biopsies of affected organs (such as the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003895.htm\" target=\"_blank\">liver</a> and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003840.htm\" target=\"_blank\">skin</a>)</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/genetictesting.html\" target=\"_blank\">Genetic testing</a></li>\r\n</ul>\r\n<a href=\"http://emedicine.medscape.com/article/203948-overview\" target=\"_blank\">More information about studies used to diagnose SM can be viewed here on the Medscape Reference website</a>.","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":4923,"authors":"Koyamangalath Krishnan","articleTitle":"Systemic Mastocytosis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 22, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/203948-workup#showall","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6468,"questionText":"How might systemic mastocytosis be treated?","answerText":"Treatment for systemic mastocytosis (SM)&nbsp;is&nbsp;based on the signs and symptoms present in each person. For example, the following medications may used to treat various symptoms associated with SM:[4923][9103]\r\n<ul>\r\n    <li>Antihistamines to treat or prevent skin and gastrointestinal symptoms</li>\r\n    <li>Proton pump inhibitors to treat increased stomach acid</li>\r\n    <li>Epinephrine to treat <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000844.htm\" target=\"_blank\">anaphylaxis</a></li>\r\n    <li>Steroids to treat <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000299.htm\" target=\"_blank\">malabsorption</a> (impaired ability to take in nutrients)</li>\r\n    <li>Mast-cell stabilizers such as <a href=\"http://www.mayoclinic.org/drugs-supplements/ketotifen-oral-route/description/drg-20064435\" target=\"_blank\">ketotifen</a> to treat some of the skin symptoms</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682713.html\" target=\"_blank\">Cromolyn sodium</a> to treat gastrointestinal symptoms, bone pain, headaches, and some of the skin manifestations</li>\r\n</ul>\r\nIf systemic mastocytosis is cancerous (mast cell leukemia) or associated with a blood disorder, <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">steroids</a> and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002324.htm\" target=\"_blank\">chemotherapy</a> may be necessary.[5535]\r\n<br />\r\n<br />\r\nMore specific information about treatment options can be accessed through the <a href=\"http://emedicine.medscape.com/article/203948-treatment#showall\" target=\"_blank\">Treatment</a> and <a href=\"http://emedicine.medscape.com/article/203948-medication#showall\" target=\"_blank\">Medication</a> sections of the Medscape Reference website.","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":4923,"authors":"Koyamangalath Krishnan","articleTitle":"Systemic Mastocytosis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 22, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/203948-workup#showall","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5535,"authors":"","articleTitle":"Mastocytosis","bookWebsiteJournalTitle":"National Institute of Allergy and Infectious Diseases (NIAID)","date":"October 2013","volume":"","pages":"","url":"http://www.niaid.nih.gov/topics/mastocytosis/Pages/Treatment.aspx","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9103,"authors":"Castells MC and Akin C","articleTitle":"Systemic mastocytosis: Treatment and prognosis","bookWebsiteJournalTitle":"UpToDate","date":"October 21 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/systemic-mastocytosis-treatment-and-prognosis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8969,"questionText":"What is the long-term outlook for people with systemic mastocytosis?","answerText":"The long-term outlook (prognosis) for people with systemic mastocytosis (SM) varies. Young children and those who present with primarily cutaneous (skin) and flushing symptoms tend to have little or no progression of the disease over a considerable length of time. Older patients and those with extensive, systemic disease involving other organ systems have a poorer prognosis. The median duration of survival is in these cases is not known but appears to be a few years.[4923]<br />\r\n<br />\r\nFeatures that may be associated with a poorer prognosis may include:[9103][4923]\r\n<ul>\r\n    <li>elevated lactate dehydrogenase levels</li>\r\n    <li>anemia</li>\r\n    <li>thrombocytopenia (low platelet count)</li>\r\n    <li>hypoalbuminemia (low albumin)</li>\r\n    <li>excess bone marrow blasts (&gt;5%)</li>\r\n    <li>high <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003470.htm\" target=\"_blank\">alkaline phosphatase</a></li>\r\n    <li>hepatosplenomegaly (enlarged liver and/or spleen)</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000286.htm\" target=\"_blank\">ascites</a></li>\r\n</ul>","dateModified":"2015-06-17T20:41:00","resourceClassificationName":"Prognosis","references":[{"referenceId":4923,"authors":"Koyamangalath Krishnan","articleTitle":"Systemic Mastocytosis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 22, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/203948-workup#showall","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9103,"authors":"Castells MC and Akin C","articleTitle":"Systemic mastocytosis: Treatment and prognosis","bookWebsiteJournalTitle":"UpToDate","date":"October 21 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/systemic-mastocytosis-treatment-and-prognosis","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":6987,"relatedDiseaseName":"Mastocytosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":58202,"abbreviatedInquiry":"My 22 year old son was diagnosed with urticaria pigmentosa in infancy and except for skin spots he is largely symptom-free. Because of increasing skin spots and elevated serum tryptase, he had bone marrow tests and was diagnosed with indolent systemic mastocytosis (ISM). He does not have other health problems and is very active. Will his symptoms worsen systemically with time or is it possible for ISM patients to remain symptom-free for life?","caseQuestions":[{"questionId":11043,"questionText":"Do symptoms of indolent systemic mastocytosis (ISM) always worsen with time, or can people with ISM remain largely symptom-free?","answerText":"Indolent systemic mastocytosis (ISM) typically progresses slowly or not at all.[9103] Symptoms do not always worsen with time. Although mast cell infiltrates can be detected in various organs (including liver, spleen, and gastrointestinal tract), the clinical course is generally <a href=\"http://c.merriam-webster.com/medlineplus/indolent\" target=\"_blank\">indolent</a>.[12145]<br />\r\n<br />\r\nFewer than 5% of people with an initial diagnosis of ISM will progress to a more severe form of systemic mastocytosis, such as:<br />\r\n<ul>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&amp;Expert=98849\" target=\"_blank\" style=\"font-size: 12pt;\">Systemic mastocytosis with an associated hematologic nonmast cell lineage disorder</a>&nbsp;<span style=\"font-size: 12pt;\">(SM-AHNMD)</span></li>\r\n    <li><a href=\"http://www.orpha.net/consor/www/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=98850\" target=\"_blank\">Aggressive systemic mastocytosis</a>&nbsp;(ASM)</li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&amp;Expert=98851\" target=\"_blank\">Mast cell leukemia</a>&nbsp;(MCL)</li>\r\n</ul>\r\n<br />\r\nProgression to one of these may occur within months to years from the initial diagnosis.&nbsp;Development of unexplained hematologic (blood-related) abnormalities, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003275.htm\" target=\"_blank\">hepatosplenomegaly</a>,&nbsp;unexplained weight loss, clotting disorders (coagulopathy), <a href=\"https://medlineplus.gov/ency/article/000286.htm\" target=\"_blank\">ascites</a>, or gastrointestinal bleeding could mean there is a possibility of disease progression.[9103]<br />\r\n<br />\r\n<span style=\"font-size: 12pt;\">While most people with ISM have normal life expectancy, severe disability and death have been reported from <a href=\"http://www.worldallergy.org/public/allergic_diseases_center/anaphylaxis/anaphylaxis.php\" target=\"_blank\">anaphylactic episodes</a>.[9103]<br />\r\n</span>\r\n<p>&nbsp;</p>","dateModified":"2016-11-11T00:00:00","references":[{"referenceId":9103,"authors":"Castells MC and Akin C","articleTitle":"Systemic mastocytosis: Treatment and prognosis","bookWebsiteJournalTitle":"UpToDate","date":"October 21 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/systemic-mastocytosis-treatment-and-prognosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12145,"authors":"Mariana C Castells and Cem Akin","articleTitle":"Systemic mastocytosis: Determining the category of disease","bookWebsiteJournalTitle":"UpToDate","date":"August, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}]},{"caseId":36673,"abbreviatedInquiry":"My mother is suffering from systemic mastocytosis. What types of treatment are available for this condition?","caseQuestions":[{"questionId":6468,"questionText":"How might systemic mastocytosis be treated?","answerText":"Treatment for systemic mastocytosis (SM)&nbsp;is&nbsp;based on the signs and symptoms present in each person. For example, the following medications may used to treat various symptoms associated with SM:[4923][9103]\r\n<ul>\r\n    <li>Antihistamines to treat or prevent skin and gastrointestinal symptoms</li>\r\n    <li>Proton pump inhibitors to treat increased stomach acid</li>\r\n    <li>Epinephrine to treat <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000844.htm\" target=\"_blank\">anaphylaxis</a></li>\r\n    <li>Steroids to treat <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000299.htm\" target=\"_blank\">malabsorption</a> (impaired ability to take in nutrients)</li>\r\n    <li>Mast-cell stabilizers such as <a href=\"http://www.mayoclinic.org/drugs-supplements/ketotifen-oral-route/description/drg-20064435\" target=\"_blank\">ketotifen</a> to treat some of the skin symptoms</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682713.html\" target=\"_blank\">Cromolyn sodium</a> to treat gastrointestinal symptoms, bone pain, headaches, and some of the skin manifestations</li>\r\n</ul>\r\nIf systemic mastocytosis is cancerous (mast cell leukemia) or associated with a blood disorder, <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">steroids</a> and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002324.htm\" target=\"_blank\">chemotherapy</a> may be necessary.[5535]\r\n<br />\r\n<br />\r\nMore specific information about treatment options can be accessed through the <a href=\"http://emedicine.medscape.com/article/203948-treatment#showall\" target=\"_blank\">Treatment</a> and <a href=\"http://emedicine.medscape.com/article/203948-medication#showall\" target=\"_blank\">Medication</a> sections of the Medscape Reference website.","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":4923,"authors":"Koyamangalath Krishnan","articleTitle":"Systemic Mastocytosis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 22, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/203948-workup#showall","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5535,"authors":"","articleTitle":"Mastocytosis","bookWebsiteJournalTitle":"National Institute of Allergy and Infectious Diseases (NIAID)","date":"October 2013","volume":"","pages":"","url":"http://www.niaid.nih.gov/topics/mastocytosis/Pages/Treatment.aspx","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9103,"authors":"Castells MC and Akin C","articleTitle":"Systemic mastocytosis: Treatment and prognosis","bookWebsiteJournalTitle":"UpToDate","date":"October 21 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/systemic-mastocytosis-treatment-and-prognosis","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":33766,"abbreviatedInquiry":"I need information on the initial tests that can be done to rule out systemic mastocytosis. What are they and should they be done after an episode or can they be done at any time?","caseQuestions":[{"questionId":5929,"questionText":"How is systemic mastocytosis diagnosed?","answerText":"A diagnosis of systemic mastocytosis (SM)&nbsp;is often suspected based on the presence of characteristic <a href=\"https://rarediseases.info.nih.gov/gard/8616/systemic-mastocytosis/resources/9\" target=\"_blank\">signs and symptoms</a>. Additional testing can then be ordered to rule out other conditions with similar features; confirm the diagnosis; determine the type; and assess the severity. These tests may include:[4923]\r\n<ul>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003934.htm\" target=\"_blank\">Bone marrow biopsy</a>&nbsp;- the most useful test used to diagnose the condition</li>\r\n    <li><a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/bdt/\" target=\"_blank\">Blood studies</a>&nbsp;- may show <a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=\"_blank\">anemia</a>, elevated <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19333.htm\" target=\"_blank\">histamine</a> levels, <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/thcp/\" target=\"_blank\">thrombocytopenia</a>, high white blood cell count (leukocytosis), low blood <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003480.htm\" target=\"_blank\">albumin</a> levels (hypoalbuminemia), or high serum <a href=\"http://labtestsonline.org/understanding/analytes/tryptase/tab/sample\" target=\"_blank\">tryptase</a> levels</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/diagnosticimaging.html\" target=\"_blank\">Imaging studies</a>&nbsp;- may help to identify the extent and stage of the disease</li>\r\n    <li>Biopsies of affected organs (such as the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003895.htm\" target=\"_blank\">liver</a> and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003840.htm\" target=\"_blank\">skin</a>)</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/genetictesting.html\" target=\"_blank\">Genetic testing</a></li>\r\n</ul>\r\n<a href=\"http://emedicine.medscape.com/article/203948-overview\" target=\"_blank\">More information about studies used to diagnose SM can be viewed here on the Medscape Reference website</a>.","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":4923,"authors":"Koyamangalath Krishnan","articleTitle":"Systemic Mastocytosis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 22, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/203948-workup#showall","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":28018,"abbreviatedInquiry":"Can heat and/or humidity affect systemic mastocytosis?","caseQuestions":[{"questionId":3717,"questionText":"Can heat and/or humidity affect systemic mastocytosis?","answerText":"Yes. Heat appears to be one of the many factors that can trigger a mast cell response.[8371]\r\n<br />\r\n<br />\r\nOther triggers include:[8371]\r\n<ul>\r\n    <li>Certain medications</li>\r\n    <li>Physical factors, such as exercise, massage or friction applied to the skin, and very spicy foods</li>\r\n    <li>Surgical procedures</li>\r\n    <li>Alcohol</li>\r\n    <li>Infections</li>\r\n    <li>Stress</li>\r\n    <li>Insect stings</li>\r\n</ul>","dateModified":"2015-06-17T00:00:00","references":[{"referenceId":8371,"authors":"Castells MC and Akin C","articleTitle":"Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations","bookWebsiteJournalTitle":"UpToDate","date":"December 5, 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15518,"phenoTypeName":"Abnormal eosinophil morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13413,"phenoTypeName":"Malabsorption","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11673,"phenoTypeName":"Mastocytosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13403,"phenoTypeName":"Nausea and vomiting","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8303,"phenoTypeName":"Urticaria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3092,"phenoTypeName":"Generalized osteosclerosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5099,"phenoTypeName":"Impaired temperature sensation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15521,"phenoTypeName":"Leukopenia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10268,"phenoTypeName":"Osteoporosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3582,"phenoTypeName":"Abnormality of the gastric mucosa","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14285,"phenoTypeName":"Acute leukemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4096,"phenoTypeName":"Ascites","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13731,"phenoTypeName":"Asthma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9566,"phenoTypeName":"Bone marrow hypocellularity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13280,"phenoTypeName":"Bone pain","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9597,"phenoTypeName":"Chronic leukemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5689,"phenoTypeName":"Cirrhosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7897,"phenoTypeName":"Osteolysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5701,"phenoTypeName":"Portal hypertension","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10710,"phenoTypeName":"Recurrent fractures","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8977,"phenoTypeName":"Sudden cardiac death","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":1136,"phenoTypeName":"Cutaneous mastocytosis","percentRanges":"-"},{"phenoTypeId":8259,"phenoTypeName":"Edema","percentRanges":"-"},{"phenoTypeId":11167,"phenoTypeName":"Erythema","percentRanges":"-"},{"phenoTypeId":8313,"phenoTypeName":"Hypermelanotic macule","percentRanges":"-"},{"phenoTypeId":8818,"phenoTypeName":"Telangiectasia macularis eruptiva perstans","percentRanges":"-"}],"medicalProducts":[{"productId":675,"genericName":"Midostaurin","tradeName":"Rydapt","tradeLink":"https://www.us.rydapt.com/","manufacturer":"","sponsor":"Novartis Oncology","indication":"Treatment of adult patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/rydapt","medlinePlusLink":""}],"EncodedName":"Systemic_mastocytosis"}